Author:
Kuczyk Markus A.,Zimmermann Reinhold,Merseburger Axel,Anastasiadis Ares,Corvin Stefan,Hartmann J.T.,Stenzl Arnulf
Reference60 articles.
1. Neoadjuvant chemotherapy in treatment of invasive transitional bladder cancer;Abol-Enein;Br. J. Urol.,1997
2. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration: Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 2003;361:1927–34.
3. Phase II trial of cyclophophamide, doxorubicin and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwestern Oncology Group Study;Al-Sarraf;Cancer Treatment Rep.,1985
4. Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy;Bajorin;J. Clin. Oncol.,1999
5. Bassi P, Pagano F, Pappagallo et al.: Neoadjuvant MVAC of invasive bladder cancer: the GUONE multicenter phase III trial. Eur Urol 33 (Suppl. 1):567.